ATP	Adenosine triphosphate
BBB	Blood–brain barrier
CED	Convection enhanced delivery
[11C]Met	L-[methyl-11C]-methionine
CNS	Central Nervous System
CT	Computerized Tomography
[64Cu][CuCl2]	Copper chloride
[62Cu][Cu(ATSM)]	[62Cu]-diacetyl-bis(N4-methylthiosemicarbazone
DMG	Diffuse midline glioma
DOTA-TATE	DOTA-Tyr3-octreotate
DOTA-TOC	DOTA-Tyr3-octreotide
DOTA-NOC	DOTA-Nal3-octreotide
DOTA-SP	DOTA-[Thi8, Met(O2)11]-substance P
ECM	Extracellular matrix
EGFR	Epidermal growth factor receptor
[18F]DCFPyL	2-(3-(1carboxy-5-(6-[18F]]fluoro-pyridine-3-carbonyl)-amino]-pentyl)-ureido)-pentanedioic acid
[18F]DOPA	3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine
[18F]FAZA	[18F]fluoroazomycin arabinoside
[18F]FDG	[18F]2-fluoro-2-deoxy-D-glucose
[18F]FET	O-(2-[18F]-fluoroethyl)-L-tyrosine
[18F]FLT	3′-deoxy-3′-[18F]fluorothymidine
[18F]FMISO	1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol
[18F]FRP-170	1-[2-[18F]Fluoro-1-(hydroxymethyl)-ethoxy]methyl-2-nitroimidazole
[68Ga]Ga-PSMA-11	[68Ga]Ga-HBED-CC-PSMA
Gd	Gadolinium
GPCR	G-protein coupled receptor
HER2	Human epidermal growth factor receptor 2
HGG	High-grade glioma
HIFU	High-intensity focused ultrasound
IA	Intra-arterial
IHC	Immunohistochemistry
IV	Intravenous
LGG	Low-grade glioma
MRI	Magnetic Resonance Imaging
NK1-R	Transmembrane neurokinin type-1 receptor
[13N]NH3	[13N]ammonia
NSCLC	Non-small cell lung cancer
OS	Overall survival
PDGFR	Platelet derived growth factor receptor
PD-L1	Programmed death-ligand 1
PET	Positron Emission Tomography
PFS	Progression free survival
ROI	Region of interest
PRRT	Peptide receptor radionuclide therapy
PSMA	Prostate-specific membrane antigen
RTK	Receptor tyrosine kinases
SPECT	Single-Photon Emission Computerized Tomography
SSTR2	Somatostatin receptor 2
SUV	Standardized uptake value
TBR	Tumor-to-background ratios
TfR1	Transferrin receptor 1
TK1	Thymidine kinase 1
TKI	Tyrosine kinase inhibitors
TSPO	Translocator protein
VEGF	Vascular endothelial growth factor
VEGFR	Vascular endothelial growth factor receptor
WHO	World Health Organization